British Journal of Medical and Health Research

BJMHR

2394-2967

10.46624/bjmhr.2021.v8.i7.004

BJMHR0807004

SARS-COV-2 Pandemic in Syria: Symptoms and Treatments

Al-Tameemi

Kanaan

Khudhur

Hasan Raheem

Dayoob

Hend

Youssef

Seba

Zuzu

Tarik

Department of Microbiology, Faculty of Medicine, Al-Andalus University for Medical Sciences, Tartous, Syria. Department of Microbiology, Faculty of Health and Medical Techniques, University of Sawa, Iraq Department of Microbiology, Faculty of Pharmacy, Al-Andalus University for Medical Sciences, Tartous, Syria

07 01 2021

8 7

ABSTRACT SARS-CoV-2 has caused global pandemic that resulted in a dramatic loss of human life worldwide. The first human case was reported in December 2019 in China, and while the first case in Syria was confirmed on March 2020. By July 1st, 2021, 25551 cases were reported in Syria with 1879 deaths. The most common symptoms of covid-19 are fever, dry cough, and shortness of breath. Some patients may endure from musculoskeletal, gastrointestinal and dermatologic symptoms. Many drugs (including antibiotics, corticosteroids, antiviral and Immunomodulatory drugs) have been evaluated and recommended to be used in COVID-19 treatment, resulting in clinical recovery. Keywords: SARS-CoV-2, Syria, pandemic, remdesivir, corticosteroids, antiviral

SARS-CoV-2 Syria pandemic remdesivir corticosteroids antiviral